NHS no longer prescribes or administers treatment as the potential risks do not justify the benefits that people may gain ...

The National Pharmacy Association (NPA) said people should not buy Kenalog, which can be advertised on social media sites or by salons and beauty clinics ...

In the US, patients diagnosed with noninfectious uveitis (NIU) are higher in number than infectious uveitis (IU). In 2022, ...

In February 2025, BioRestorative Therapies announced that the FDA cleared its Investigational New Drug (IND) application for ...

Aim To evaluate the long-term outcomes of intravitreal triamcinolone acetonide (TA) administration after posterior vitreous detachment (PVD) during pars plana vitrectomy (PPV) for patients with ...

Am J Health Syst Pharm. 2005;62(5):485-491. A stock solution of triamcinolone acetonide standard m was prepared in ethanol and diluted to yield concentrations of 2, 4, 8, 12, and 16 µg/mL ...

Find Injective (INJ) price predictions for 2025, 2026 and 2030. Discover key investment factors, risks and analyst forecasts for this leading DeFi blockchain.

LONDON, UK – 24–25 June 2025. Projected to reach $1,139.4 billion by 2029, the injectable drug delivery market is rapidly growing—but what’s driving this evolution?

SAE Media Group's 15th Annual Pre-Filled Syringes and Injectable Drug Devices Conference 2023 will be bigger than ever, with a pre-conference focus day exploring the advances in PFS design for ...

Triamcinolone (Kenalog) is not licensed for eye use but has been used to treat DMO for over 10 years. Triamcinolone ... similar efficacy as ranibizumab combined with laser in pseudophakic eyes.21, 46 ...

Injection of a hydrogel loaded with drugs with simultaneous anti-inflammatory and tissue regenerating properties can be an effective treatment for promoting periodontal regeneration in periodontitis.